What's new in WHO fifth edition - urinary tract.

Compérat, Eva; Amin, Mahul B; Berney, Dan M; Cree, Ian; Menon, Santosh; Moch, Holger; Netto, George J; Rao, Vishal; Raspollini, Maria Rosaria; Rubin, Mark A; Srigley, John R; Tan, Puay Hoon; Tickoo, Satish Kumar; Turajlic, Samra; Tsuzuki, Toyonori (2022). What's new in WHO fifth edition - urinary tract. Histopathology, 81(4), pp. 439-446. Wiley 10.1111/his.14764

Full text not available from this repository.

The fifth edition of the WHO Blue Book on urological tumours, specifically in the bladder chapter, represents a refinement and update in the classification of bladder tumours building on the aggregate major changes made in previous editions. Progress in the molecular underpinnings of urothelial tumours, particularly with promising stratifiers for more precision-based treatment approaches, have been made. Special attention has been paid to burning questions in bladder pathology, such as grading, heterogeneous lesions, inverted tumours and substaging. The concept of neuroendocrine tumours will be explained precisely.

Item Type:	Journal Article (Review Article)
Division/Institute:	04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Präzisionsonkologie 04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Präzisionsonkologie 04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR)
UniBE Contributor:	Rubin, Mark Andrew
Subjects:	600 Technology > 610 Medicine & health
ISSN:	1365-2559
Publisher:	Wiley
Language:	English
Submitter:	Jasmine Stiefel
Date Deposited:	14 Dec 2022 07:31
Last Modified:	14 Dec 2022 18:39
Publisher DOI:	10.1111/his.14764
PubMed ID:	35942645
Uncontrolled Keywords:	bladder cancer heterogenous tumours inverted lesions molecular stratification staging
URI:	https://boris.unibe.ch/id/eprint/175825